Regeneron Pharmaceuticals Inc (REGN) — Financial Flexibility Index
Regeneron Pharmaceuticals Inc (REGN) has a Financial Flexibility Index of 0.14x as of March 2026. Free cash flow of $1.31 Billion (operating CF $1.08 Billion minus capex $230.60 Million) represents 0% of total liabilities ($9.45 Billion). Also explore REGN shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Regeneron Pharmaceuticals Inc Financial Flexibility Index (1991–2025)
Historical Financial Flexibility Index trend for Regeneron Pharmaceuticals Inc across 35 annual periods. Check REGN strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Regeneron Pharmaceuticals Inc (1991–2025)
Year-by-year free cash flow to debt coverage for Regeneron Pharmaceuticals Inc. For the full company profile including market capitalisation, see REGN stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.63x | $5.88 Billion | $4.98 Billion | $9.30 Billion | ▲ +2.6% |
| 2024 | 0.62x | $5.18 Billion | $4.42 Billion | $8.41 Billion | ▼ -20.7% |
| 2023 | 0.78x | $5.52 Billion | $4.59 Billion | $7.11 Billion | ▼ -9.2% |
| 2022 | 0.86x | $5.61 Billion | $5.01 Billion | $6.55 Billion | ▼ -25.3% |
| 2021 | 1.15x | $7.63 Billion | $7.08 Billion | $6.67 Billion | ▲ +117.4% |
| 2020 | 0.53x | $3.23 Billion | $2.62 Billion | $6.14 Billion | ▼ -31.6% |
| 2019 | 0.77x | $2.86 Billion | $2.43 Billion | $3.72 Billion | ▼ -11.1% |
| 2018 | 0.87x | $2.58 Billion | $2.20 Billion | $2.98 Billion | ▲ +43.6% |
| 2017 | 0.60x | $1.58 Billion | $1.31 Billion | $2.62 Billion | ▼ -23.8% |
| 2016 | 0.79x | $2.00 Billion | $1.49 Billion | $2.52 Billion | ▼ -23.0% |
| 2015 | 1.03x | $2.01 Billion | $1.33 Billion | $1.95 Billion | ▲ +25.9% |
| 2014 | 0.82x | $1.09 Billion | $752.43 Million | $1.33 Billion | ▲ +9.5% |
| 2013 | 0.75x | $744.92 Million | $588.60 Million | $998.94 Million | ▲ +2563.6% |
| 2012 | -0.03x | $-25.28 Million | $-74.61 Million | $835.11 Million | ▲ +70.0% |
| 2011 | -0.10x | $-84.47 Million | $-141.68 Million | $837.85 Million | ▼ -128.9% |
| 2010 | 0.35x | $196.03 Million | $96.34 Million | $561.62 Million | ▲ +379.2% |
| 2009 | 0.07x | $25.09 Million | $-72.23 Million | $344.44 Million | ▲ +133.7% |
| 2008 | -0.22x | $-54.23 Million | $-89.09 Million | $251.19 Million | ▼ -324.3% |
| 2007 | 0.10x | $45.82 Million | $27.37 Million | $475.99 Million | ▲ +37.0% |
| 2006 | 0.07x | $25.89 Million | $23.07 Million | $368.47 Million | ▲ +185.8% |
| 2005 | -0.08x | $-25.33 Million | $-30.30 Million | $309.50 Million | ▼ -121.5% |
| 2004 | -0.04x | $-10.73 Million | $-16.91 Million | $290.56 Million | ▼ -153.7% |
| 2003 | 0.07x | $23.52 Million | $-6.13 Million | $341.91 Million | ▲ +122.2% |
| 2002 | -0.31x | $-76.15 Million | $-110.52 Million | $245.59 Million | ▼ -44.7% |
| 2001 | -0.21x | $-49.10 Million | $-57.32 Million | $229.04 Million | ▲ +73.8% |
| 2000 | -0.82x | $-21.41 Million | $-27.91 Million | $26.14 Million | ▼ -178.1% |
| 1999 | -0.29x | $-8.10 Million | $-13.80 Million | $27.50 Million | ▼ -5.1% |
| 1998 | -0.28x | $-7.20 Million | $-10.20 Million | $25.70 Million | ▼ -106.6% |
| 1997 | -0.14x | $-4.00 Million | $-6.10 Million | $29.50 Million | ▲ +64.4% |
| 1996 | -0.38x | $-11.70 Million | $-20.30 Million | $30.70 Million | ▲ +33.8% |
| 1995 | -0.58x | $-14.90 Million | $-18.20 Million | $25.90 Million | ▼ -14.6% |
| 1994 | -0.50x | $-13.60 Million | $-20.50 Million | $27.10 Million | ▲ +51.6% |
| 1993 | -1.04x | $-19.90 Million | $-30.10 Million | $19.20 Million | ▲ +26.6% |
| 1992 | -1.41x | $-15.10 Million | $-17.20 Million | $10.70 Million | ▼ -89.8% |
| 1991 | -0.74x | $-5.80 Million | $-6.80 Million | $7.80 Million | — |